1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research (SBIR) Program (DoD) (DARPA) is sponsored by Defense Advanced Research Projects Agency (DARPA), U.S. Department of Defense (DoD). The DARPA SBIR program funds U.S. small businesses to develop innovative technologies, including AI, to advance national security. This is part of the broader DoD SBIR/STTR program, focusing on high-risk, high-payoff research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U.S. small businesses developing innovative technologies with potential for national security and commercialization. Confirm the full requirements in the official notice before applying.
The current listing shows varies by topic and phase (Phase I up to $275,000; Phase II up to $1.5 million or more). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Small Business Innovation Research (SBIR) Program (DoD) (DARPA) are due October 21, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Small Business Innovation Research (SBIR) Program (DoD) (DARPA) is funded by Defense Advanced Research Projects Agency (DARPA), U.S. Department of Defense (DoD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
SBIR Phase I — US Small Business Innovation is sponsored by Defense Advanced Research Projects Agency (DARPA). This program provides early-stage funding for highly innovative R&D projects, with active funding areas including blockchain for federal applications, decentralized identity, AI safety, and quantum computing. It is non-dilutive and open to US-based small businesses.
Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) is sponsored by Defense Health Agency Contracting Activity - DHACA. This award supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to improved patient outcomes, with a focus on well-formulated, testable hypotheses and strong scientific rationale.
Pancreatic Cancer Research Program (PCARP) Patient-Centered Focus Area Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP), Department of Defense. This award supports the exploration and development of impactful and innovative concepts under a patient-centered focus that could ultimately lead to major advancements in patients' overall quality of life.
The Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDARPA's FY26 Release 6 carries seven SBIR and three STTR topics closing October 21, 2026. TRIAGE-X and ICU-in-a-Box are listed at $2 million each, CORPS at $750,000 — not Phase I feasibility money. Meanwhile DoW FY-27 Release 1 pre-released October 7 with 25 topics, zero of them DARPA's, and a new one-proposal-per-topic rule that took effect October 1. Here is how to read both calendars.
Read articleDPA26BZ06-DV023 is a Direct-to-Phase-II SBIR paying $700,000 over 18 months plus a $500,000 option. The physics demands 256x more transmit power than the systems that qualify you to compete, and DARPA will not accept modeling alone as proof. Here is the eligibility wall, the five engineering problems, and who can realistically win it before the October 21 close.
Read article